HomeAI · summaries
Storia in 3 fonti
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
nbcnews.com
What to know about the seven peptides an FDA advisory panel is set to review this week
The committee will discuss whether compounding pharmacies can make the peptides in question. But FDA scientists say there’s little — if any — evidence they work in humans.
- ·
fortune.com
The FDA’s peptide vote could create telehealth's next multibillion-dollar market | Fortune
As regulators weigh whether pharmacies can legally compound wellness peptides, companies are preparing for a repeat of the GLP-1 boom—only this time with even murkier science.
